Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Bausch Health Companies Inc
(NY:
BHC
)
9.655
+0.395 (+4.27%)
Streaming Delayed Price
Updated: 3:53 PM EST, Nov 5, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Bausch Health Companies Inc
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Salix in Collaboration with The U.S. Pain Foundation and the International Foundation for Gastrointestinal Disorders Establish the Inaugural Opioid-Induced Constipation (OIC) Awareness Day
December 05, 2023
Via
ACCESSWIRE
Bausch Health Companies Inc. (NYSE:BHC) Long Term Shareholder Notice: Investigation of Potential Wrongdoing
December 01, 2023
San Diego, CA -- (SBWIRE) -- 12/01/2023 -- An investigation on behalf of current long-term investors in shares of Bausch Health Companies Inc. (NYSE:BHC) concerning potential breaches of fiduciary...
Via
SBWire
The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
November 10, 2023
Via
ACCESSWIRE
CORRECTION BY SOURCE: The Absence of an Overt Hepatic Encephalopathy (OHE)-Specific Diagnosis Code May Result in Increased OHE-Related Length of Stay and Hospitalization-Related Costs Due to OHE Rate Underestimation, According to New Analysis
November 10, 2023
Via
ACCESSWIRE
As Daylight Saving Time Comes to a Close, Bausch Health Champions Mental Health with a Spotlight on Preventing Seasonal Affective Disorder (SAD)
November 08, 2023
Via
ACCESSWIRE
Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week
October 30, 2023
S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Bausch Health Unveils "Looking Forward" - A New DTC Television Campaign for Seasonal Affective Disorder (SAD)
October 26, 2023
Via
ACCESSWIRE
Salix Pharmaceuticals Partners with Bellamy Young
October 04, 2023
Via
ACCESSWIRE
US Stocks On Track For Solid Start Amid Lingering Fed Optimism: Traders Eye Earnings From Market Bellwether Apple
November 02, 2023
After the Federal Reserve‘s decision, the stock market rally is poised to gain momentum on Thursday, with stock futures indicating an uptick.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Bausch Health Announces Third-Quarter 2023 Results
November 02, 2023
Via
ACCESSWIRE
Wall Street On Track For Another Win Amid Interest Rate Buzz
November 01, 2023
Wall Street is looking to extend a winning streak, as investors prepare for the Federal Reserve's latest interest rate decision.
Via
Talk Markets
Topics
Economy
Exposures
Interest Rates
League of United Latin American Citizens (LULAC) Joins OraPharma in the Fight Against Gum Disease
September 21, 2023
Via
ACCESSWIRE
Why Bausch Health Stock Is Jumping Today
September 20, 2023
Investors appear to be shaking off their concerns about Bausch Health's CFO turnover.
Via
The Motley Fool
U.S. District Court Dismisses Norwich's Lawsuit Against the FDA
November 01, 2023
Via
ACCESSWIRE
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
The U.S.
Via
Benzinga
Exposures
Product Safety
FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older
October 20, 2023
Via
ACCESSWIRE
New Analysis Indicates That a Majority of Overt Hepatic Encephalopathy (OHE) Patients May Face Delays in Treatment Initiation and Gaps During Treatment for Access to Treatment Indicated to Reduce Risk for OHE Recurrence
October 17, 2023
Via
ACCESSWIRE
Bausch Health to Announce Third-Quarter 2023 Results on Nov. 2
October 12, 2023
Via
ACCESSWIRE
Salix Pharmaceuticals Releases Liver Health Annual Trends Report Identifying Increase in Chronic Liver Disease and Cirrhosis-Related Deaths Marking These as Ninth Leading Cause of Death in U.S.
October 10, 2023
Via
ACCESSWIRE
Bausch Health's Bausch + Lomb Announces Completion of the Acquisition of XIIDRA(R)
September 29, 2023
Via
ACCESSWIRE
BHC DEADLINE TODAY: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action – BHC
September 25, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
BHC FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
September 24, 2023
WHY: NEW YORK, NY - (NewMediaWire) - September 23, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Bausch Health Companies Inc. (NYSE: BHC) between August...
Via
TheNewswire.com
Topics
Lawsuit
Exposures
Financial
Legal
BHC FINAL DEADLINE ALERT: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Bausch Health Companies Inc. Investors to Secure Counsel Before Important September 25 Deadline in Securities Class Action - BHC
September 23, 2023
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
BAUSCH DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Bausch Health Companies, Inc. and Encourages Investors to Contact the Firm
September 22, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Bausch Health Companies Inc. (BHC)
September 22, 2023
From
Law Offices of Frank R. Cruz
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
September 20, 2023
Via
Benzinga
Steelcase, Western Digital, Bausch Health And Other Big Stocks Moving Higher On Wednesday
September 20, 2023
U.S. stocks traded mostly higher on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
BAUSCH HEALTH COMPANIES INC. (NYSE: BHC) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Bausch Health Companies Inc.
September 20, 2023
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Why Shares of Bausch Health Companies Fell Tuesday
September 19, 2023
The company announced a chief financial officer transition plan.
Via
The Motley Fool
7 Cannabis Stocks to Buy BEFORE the Marijuana Rescheduling Boom
September 19, 2023
Cannabis stocks re seeing renewed interest and these seven look like reasonable buys as rescheduling approaches for weed.
Via
InvestorPlace
Topics
Cannabis
Exposures
Cannabis
< Previous
1
2
3
4
5
6
7
8
9
...
11
12
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.